PET tracer manufacturing and distribution
Making PSMA, FDG, and new tracers under drug-manufacturing rules and delivering them daily.
FDA-approved PET drugs are made under cGMP at commercial radiopharmacies (PETNET, Cardinal Health, SOFIE, Jubilant, Curium) or academic sites under ANDA/NDA. New tracers (PSMA agents from Lantheus, Telix, Novartis; FES; FAPI in trials) rely on these networks for launch reach. Kits (Illuccix, Locametz) versus centrally produced doses (Pylarify) is a business-model divide.
How it works
Automated radiosynthesis modules, cassette-based chemistry, and rapid QC (radiochemical purity, endotoxin) before release.
- Daily national coverage in the US and Europe
- Tracer approval per site
- Kit vs central-dose economics
- Limited reach in low-income countries
Latest papers
topQuery for this technology: (TITLE:"PET tracer manufacturing and distribution" OR ABSTRACT:"PET tracer manufacturing and distribution") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PET tracer manufacturing and distribution, not a curated reading list.